IDEXX Laboratories, Inc. Common Stock (NASDAQ: IDXX) last traded at $523.94, up 1.15% on the session. The quote above updates while this page is open; the figures below are drawn from IDEXX Laboratories, Inc. Common Stock’s own filings and are restated only when a new one is published.
IDEXX Laboratories, Inc. Common Stock trades on NASDAQ under the ticker IDXX. Its market capitalisation is $41.28 billion.
Valuation measures for IDEXX Laboratories, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $41.28B |
|---|---|
| Enterprise value | $42.91B |
| P/E ratio | 36.82 |
| Price / sales | 9.07 |
| Price / book | 25.60 |
| Beta | 0.84 |
Trailing-twelve-month figures tagged in IDEXX Laboratories, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $4.55B |
|---|---|
| Net income (TTM) | $1.14B |
| EPS (TTM) | $14.23 |
| Gross margin | 62.45% |
| Operating margin | 32.03% |
| Return on equity | 70.67% |
| Cash | $196.93M |
Range and volume for IDXX over the past 52 weeks.
| 52-week high | $769.98 |
|---|---|
| 52-week low | $500.61 |
| Volume | 552.8K |
| Average volume | 551.7K |
| Previous close | $518.00 |
Invest a chosen dollar amount in IDEXX Laboratories, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell IDXX.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.